Buster, good article, thumbs up function appears broken...
Aside from others in pharma, the broader potential application for CVAC does make me wonder if DNDN itself will come to think that a take-over by them would allay market criticisms that they are a 'one trick' pony.
Notwithstanding that DNDN may be fully occupied with ramping up production of provenge and moving into the European market.
coincidence - transcu - jp morgan - prima, page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.015(3.95%) |
Mkt cap ! $530.2M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 36.5¢ | $413.2K | 1.123M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103704 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 68352 | 2 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |